SCHEMBL23948717

SCHEMBL23948717

c1ccc(-n2c3ccccc3c3c4c5ccncc5n5c6ccccc6nc5c4c4c5ccccc5n(-c5ccccc5)c4c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HPGD P15428 5/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
PDE10A Q9Y233 2/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
PDE2A O00408 1/20 0.35
AOC3 Q16853 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23948304 0.92 KDM4E (0.39) KDM4EMAPTLMNATP53POLB
SCHEMBL23948398 0.84 KDM4E (0.36) KDM4EMAPTLMNATP53POLB
SCHEMBL23948884 0.82 KDM4E (0.40) KDM4EMAPTLMNATP53POLB
SCHEMBL23948443 0.81 KDM4E (0.39) KDM4EMAPTLMNATP53POLB
SCHEMBL21298168 0.80 KDM4E (0.43) KDM4EMAPTLMNATP53POLB
SCHEMBL22649114 0.80 KDM4E (0.47) KDM4EMAPTLMNATP53POLB
SCHEMBL22648980 0.80 KDM4E (0.47) KDM4EMAPTLMNATP53POLB
SCHEMBL23949030 0.80 KDM4E (0.36) KDM4EMAPTLMNATP53POLB
SCHEMBL24290644 0.79 KDM4E (0.42) KDM4EMAPTLMNATP53POLB
SCHEMBL24290642 0.79 KDM4E (0.42) KDM4EMAPTLMNATP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 KDM4E 2817/4885MAPT 1313/4885LMNA 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.